Vireo Health Announces Participation at Benzinga Cannabis Capital ConferencePosted by On

MINNEAPOLIS, Oct. 13, 2020 /PRNewswire/ — Vireo Health International, Inc. (“Vireo” or the “Company”) (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the Commonwealth of Puerto Rico, today announced that Chief Medical Officer, Stephen Dahmer, M.D., will be participating at the Benzinga Cannabis Capital Conference on October 15, 2020.

Dr. Dahmer will serve on a panel discussion titled, “The Science Behind the Plant,” at 11:00 am E.T., and he will also give a separate presentation at 3:45 pm E.T. on long-term opportunities in medical cannabis and highlight some of Vireo’s clinical research trials that are currently underway. Interested parties may sign up to get a free spectator pass for these events at https://events.benzinga.com/register-ccc-october. For more information on the Benzinga conference, visit

Original Author Link click here to read complete story..

News

AnnouncesBenzingacannabisCapitalConferencehealthParticipationVireo

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.